 |
인쇄하기
취소
|
Abbott to receive returned goods of Reductil from pharmacy
Abbott Korea has sent a circular letter to proprietors of pharmacy and wholesalers that it will receive returned goods of Reductil (sibutramine), an obesity drug, from the market until November 11 at the latest.
The company already notified healthcare professionals and patients about the voluntary withdrawal of Reductil from the domestic market because of clinical trial data indicating an in...
The company already notified healthcare professionals and patients about the voluntary withdrawal of Reductil from the domestic market because of clinical trial data indicating an in...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.